Berestjuk et al. reported that extracellular matrix (ECM) derived from CAFs abrogate the anti-melanoma effects of BRAF/MEK inhibition in melanoma through discoidin domain receptors (DDR)1 and DDR2 phosphorylation [102]. The gene discussed is DDR2; the disease is melanoma.